Opinion

B

Blogs

Trending on Urology Times

How PSMA-PET shapes staging and recurrence workup in prostate cancer

ESMO 2026: Key presentations across genitourinary oncology

Darolutamide associated with less cognitive change than enzalutamide in prostate cancer

European Commission approves perioperative pembrolizumab plus enfortumab vedotin for MIBC

Engy Habashy, MD, on the role of androgens in GSM management